ADXS Advaxis Inc

Price (delayed)

$0.062

Market cap

$112,870

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.7

Enterprise value

-$31.95M

Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live ...

Highlights
The quick ratio has soared by 125% YoY and by 21% from the previous quarter
Advaxis's EPS has soared by 68% YoY and by 17% from the previous quarter
ADXS's revenue has plunged by 83% YoY and by 69% from the previous quarter
The gross profit has plunged by 83% YoY and by 69% from the previous quarter

Key stats

What are the main financial stats of ADXS
Market
Shares outstanding
1.82M
Market cap
$112,870
Enterprise value
-$31.95M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0
Price to sales (P/S)
0.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-63.89
Earnings
Revenue
$500,000
EBIT
-$11.48M
EBITDA
-$11.36M
Free cash flow
-$14.76M
Per share
EPS
-$6.7
Free cash flow per share
-$8.11
Book value per share
$19.31
Revenue per share
$0.27
TBVPS
$18.84
Balance sheet
Total assets
$37.52M
Total liabilities
$2.37M
Debt
$27,000
Equity
$35.15M
Working capital
$31.81M
Liquidity
Debt to equity
0
Current ratio
14.44
Quick ratio
13.56
Net debt/EBITDA
2.82
Margins
EBITDA margin
-2,272.2%
Gross margin
100%
Net margin
-2,316.6%
Operating margin
-3,133.8%
Efficiency
Return on assets
-27.7%
Return on equity
-32.1%
Return on invested capital
N/A
Return on capital employed
-32.7%
Return on sales
-2,296.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADXS stock price

How has the Advaxis stock price performed over time
Intraday
-13.77%
1 week
-1.43%
1 month
-27.06%
1 year
-88.08%
YTD
-60.15%
QTD
-47.77%

Financial performance

How have Advaxis's revenue and profit performed over time
Revenue
$500,000
Gross profit
$500,000
Operating income
-$15.67M
Net income
-$11.58M
Gross margin
100%
Net margin
-2,316.6%
Advaxis's operating margin has shrunk by 168% QoQ
The net margin has dropped by 164% since the previous quarter
ADXS's revenue has plunged by 83% YoY and by 69% from the previous quarter
The gross profit has plunged by 83% YoY and by 69% from the previous quarter

Growth

What is Advaxis's growth rate over time

Valuation

What is Advaxis stock price valuation
P/E
N/A
P/B
0
P/S
0.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-63.89
Advaxis's EPS has soared by 68% YoY and by 17% from the previous quarter
The P/B is 100% below the 5-year quarterly average of 1.4 and 100% below the last 4 quarters average of 1.0
ADXS's equity is down by 26% YoY and by 9% QoQ
The P/S is 99% lower than the 5-year quarterly average of 30.6 and 99% lower than the last 4 quarters average of 18.5
ADXS's revenue has plunged by 83% YoY and by 69% from the previous quarter

Efficiency

How efficient is Advaxis business performance
Advaxis's ROS has plunged by 163% from the previous quarter
The company's return on equity rose by 45% YoY and by 4.7% QoQ
ADXS's ROA is up by 42% YoY and by 2.8% from the previous quarter

Dividends

What is ADXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADXS.

Financial health

How did Advaxis financials performed over time
The current ratio has surged by 128% year-on-year and by 25% since the previous quarter
The quick ratio has soared by 125% YoY and by 21% from the previous quarter
The debt is 100% smaller than the equity
ADXS's equity is down by 26% YoY and by 9% QoQ
The debt has declined by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.